Skip to main content

Business Intelligence

By Beth Jones Sanborn | 05:22 pm | January 31, 2018
The increase represents a substantial impact, especially given the use of many high-cost drugs, the report says. The firm also points to biosimilars as opportunity to thwart spending.
By Tom Sullivan | 12:12 pm | January 31, 2018
The entire ecosystem is changing, forcing smart CIOs to keep pace or face significant disruption.
By Susan Morse | 04:15 pm | January 29, 2018
The organizations use voice recognition and artificial intelligence to build interactive reports that include more elements than simply what a clinician adds, such as images, charts and graphs.
By Jeff Lagasse | 01:20 pm | January 24, 2018
The growth in expenses is attributed largely to rising prices for emergency department visits, surgery and prescription drugs.
By Beth Jones Sanborn | 11:14 am | January 19, 2018
Knee-deep in the integration process, Robert Musslewhite says the company will be focusing on analytics, best practices, research and broadening its portfolio of services.
By Jeff Lagasse | 12:59 pm | January 16, 2018
The analysis cited uncertainty surrounding the tax and healthcare bills as one of the major contributors to the dip, along with a tight labor market.
By Jeff Lagasse | 03:52 pm | January 15, 2018
Meanwhile, prescription drug prices jumped 1 percent after a 0.6 percent rise late last year.
By Jeff Lagasse | 01:15 pm | January 15, 2018
Since 2008, executives and employees of the companies have invested more than $30 million in the three real estate investment trusts.
By Jeff Lagasse | 12:58 pm | December 29, 2017
Some providers make a policy of referring anyone without insurance to public hospitals, creating duplicate visits and diagnostic testing that strains those already struggling institutions.
By Jeff Lagasse | 04:01 pm | December 28, 2017
The Citizens Commission on Human Rights called for increased monitoring of psychiatric hospitals to ensure patient safety.